Tag Archives: Lubrizol

Lubrizol Reorganizes its Personal, Home and Health Care Business Lines

(BRK.A), (BRK.B)

The Lubrizol Corporation has announced the reorganization of its Personal, Home and Health Care business lines, integrating them under a newly dedicated brand, Lubrizol Life Science.

The change reflects the company’s commitment to evolve with the beauty, health, home and wellness markets, which continue to cross over and converge. The newly formed Lubrizol Life Science team seeks to enhance the value of its solutions and services to customers and end users through its collective expertise in chemistry, applications and market insights.

“Lubrizol Life Science brings together a great variety of formulation and product development experience to sit under one umbrella,” says Lubrizol Advanced Materials President Rick Tolin. “Our internal capabilities are focused and aligned to help our customers quickly meet the expectations of today’s consumers for products that ensure them of a healthier, more beautiful and comfortable life.”

The newly aligned Lubrizol Life Science team is placing a priority on developing and testing products in partnership with customers, engineering breakthroughs and co-driving initiatives that fuel growth. Practices and processes emphasize agile innovation, enabling the organization to act at the speed of a start-up, while responding with the reach, resources and delivery of a global leader. The new brand will also emphasize the proactive innovation needed to bring market-ready solutions to customers, while capitalizing on the reliability of Lubrizol’s 90 years of science and efficacy.

Tolin points out, “Our beauty, health and home customers can count on us bringing truly differentiated products to market, formulated with ingredients that are consumer-driven and backed by the reliability of Lubrizol.” Tolin adds, “The Lubrizol Life Science team is poised to service customers throughout the value chain, from concept to commercialization. Once viewed by customers as a chemical and ingredient supplier, we have evolved into an essential, concept-to-commercialization solutions partner.”

Lubrizol Life Science also plans to add strategic technology, capability and talent by investing to expand its portfolio, including new acquisitions that bring unique opportunities and synergies.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Corporation Acquires Bavaria Medizin Technologie GmbH

(BRK.A), (BRK.B)

The Lubrizol Corporation has acquired Bavaria Medizin Technologie GmbH (BMT), an innovative designer and manufacturer of both intravascular (coronary, peripheral, and cranial) and nonvascular devices, including drug-coated balloons, by its German subsidiary Lubrizol Deutschland GmbH from its current majority shareholder Custos Vermögensverwaltungs GmbH as well as from the minority shareholders.

This acquisition builds upon Lubrizol’s expertise in precision thermoplastic extrusion and product development, establishing Lubrizol as a true end-to-end partner to the global medical device and pharmaceutical industries.

With over 100 employees, BMT is headquartered near Munich, Germany and operates a manufacturing facility in Sibiu, Romania. A pioneer in catheter-based technologies, BMT developed the first commercial drug-coated balloon, the Paccocath™ catheter. Today, BMT holds over 50 patents and continues to innovate through self-funded R&D projects, as well as contract R&D services.

Additionally, BMT offers private label manufacturing of proprietary catheters and balloons along with original equipment manufacturing (OEM) services, which include the manufacturing of subassemblies and components, sterilization, packaging and labeling, stent crimping, and logistics management.

The acquisition of BMT expands Lubrizol’s product design, development, and manufacturing expertise and provides access to proprietary catheter and balloon technologies. BMT’s experience and reputation in the drug-coated balloon (DCB) space aligns well with Lubrizol’s pharmaceutical CDMO business and positions Lubrizol as the ideal partner for developing next generation DCBs.

“Lubrizol continues to invest in opportunities that position us as a full-service development partner for innovative OEMs in the interventional space,” said Uwe Winzen, general manager of the Health business of Lubrizol Life Science. “Our customers will benefit from additional design capabilities, an increased global footprint, and synergies with our existing formulation and manufacturing services.”

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Announces Global Collaboration with Corbion

(BRK.A), (BRK.B)

The Lubrizol Corporation has created an exclusive global partnership with Corbion Biotech, Inc, bringing AlgaPur(TM) high stability high oleic algae oil to the personal care and cosmetics markets.

Based in the Netherlands, Corbion is a global market leader in algae ingredients. This collaboration combines Lubrizol’s formulation experience and knowledge of the personal care market with Corbion’s innovative bio-based solutions and sustainable practices.

AlgaPur(TM) High Stability High Oleic Algae Oil is a unique algae oil with formulation and performance benefits for a diverse range of personal care applications. Key benefits include:

• Elegant sensory experience: Silky, non-greasy feel providing excellent hydration and ease of spreadability
• Stable for formulating: Superior oxidative stability with over 90% Omega-9 oleic acid, allowing for extended shelf life
• Mild formulations: Free from known allergens, low odor and neutral color
• Sustainable production: Palm-free, and produced with a low carbon, land and water footprint

Bio-based ingredients and sustainable solutions are a developing trend in the personal care industry, experiencing significant global growth. “This new collaboration allows our innovation teams to expand our formulation expertise, bringing innovative bio-based solutions with excellent performance attributes,” states Jean Claude Deneuville, global director agile businesses at Lubrizol.

“Working with Lubrizol provides the opportunity to expand access and adoption of AlgaPur(TM) High Stability High Oleic Algae Oil in the personal care market,” says Marc den Hartog, executive vice president of Innovation Platforms at Corbion. “Corbion’s unique algae oil ingredient is a versatile, new ingredient for formulators to help meet consumers demands for sustainable, traceable and high-performance products.”

Corbion is the global market leader in lactic acid, lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals, vitamins and algae ingredients. Corbion is a global player in personal care, offering natural, safe and cost-effective ingredients, widely known for its their emulsification, moisturizing, pH adjustment and antimicrobial functions.

In 2018, Corbion generated annual sales of € 897.2 million and had a workforce of 2,040 FTE.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Aims to Make Footwear 100% Recyclable

(BRK.A), (BRK.B)

According to the U.S. Department of the Interior, Americans alone throw away at least 300 million pairs of shoes each year. These shoes end up in landfills, where they can take 30 to 40 years to decompose. This figure has inspired Lubrizol Engineered Polymers to engineer an innovative portfolio of advanced polymers to provide footwear producers the opportunity to create a nearly 100% TPU shoe that is recyclable* without compromising performance.

Justin Park, Lubrizol’s global market segment manager for performance footwear says, “The advantage of a 100% TPU shoe is that at the end of the shoe’s wear cycle it can be re-grinded and then reformed into a new shoe, therefore extending the life of the product and material.”

Lubrizol Engineered Polymers advanced TPU portfolio for footwear applications gives footwear producers the opportunity to collaborate with one solution provider for their needs. Another benefit to footwear producers of using Lubrizol Engineered Polymers TPU as the prime material for shoe production is having the ability to reuse the scraps, resulting in less unused material during the manufacturing process.

The key technologies in Lubrizol’s Engineered Polymers TPU portfolio for performance footwear that can be engineered to form almost every component of a shoe include Esdex(TM) TPU for upper yarns to keep shoe construction smart and lightweight, BounCell-X(TM) a low density, plasticizer-free, recyclable*, thermoplastic foam for cushioning, Estane(R) TRX TPU as a functional alternative to rubber outsoles, Pearlthane(TM) ECO TPU a bio-based** renewable-sourced material, Estane(R) 3D TPU a soft, flexible material that offers design freedom for 3D printed components, and Pearlbond(TM) TPU for adhesives assembly that provides flexibility to join a large variety of substrates together.

Lubrizol Engineered Polymers has released a video to help support and promote its extensive TPU footwear portfolio for performance footwear applications, One Shoe.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol to Build Plant in Chiba, Japan

(BRK.A), (BRK.B)

The Lubrizol Corporation will build a new plant within the Ichihara Works (Ichihara City, Chiba, Japan) to manufacture LUCANT(TM) hydrocarbon-based synthetic fluid.

LUCANT is a high performance, hydrocarbon-based, specialty synthetic fluid used primarily as a viscosity modifier. It is used in the most demanding applications including automotive driveline, industrial lubricants and greases, and is the approved choice for leading OEMs and global oil marketers. Mitsui Chemicals was the first manufacturer to offer this unique synthetic fluid which boasts industry leading efficiency and durability.

“This investment in additional LUCANT capacity will allow the Lubrizol Additives business to further optimize its strategic relationship with Mitsui Chemicals to meet the evolving and demanding needs of lubricant market, while ensuring we remain a trusted, reliable and secure supply partner,” said Barrie Masters, global business director for the viscosity modifier business at Lubrizol.

Commercial operation at the new plant is planned for 2021 and Mitsui Chemicals, Inc. and The Lubrizol Corporation are excited to further invest in their partnership.

In 2014, Lubrizol entered into an exclusory agreement with Mitsui Chemicals, Inc. to become the exclusive worldwide seller and marketer of the LUCANT polymer products in the lubricant industry.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol’s Diamond Dispersions Business Wins Queen’s Award for International Trade

(BRK.A), (BRK.B)

The Lubrizol Corporation has announced its Sheffield, UK-based Diamond Dispersions business has won the Queen’s Award for International Trade for outstanding short-term growth.

The award was presented for growth in overseas sales over the last three years.

Since 1966, the Queen’s Award for Enterprise recognizes British businesses that excel in four categories, including International Trade, Innovation, Sustainable Development and Promoting Opportunity. It is the highest official UK awards program.

Diamond Dispersions, which manufactures color concentrates used in the manufacture of inkjet inks, mainly for the digital printing of textiles, is no stranger to this accolade having previously won the Queen’s Award for International Trade in 2012. Overseas sales have more than doubled over the past three years, and the proportion of sales exported has increased to over 80% of total sales.

“We couldn’t be prouder to receive recognition for our continued efforts and commitment to grow the company in such a prestigious way”, says Keith Malone, commercial manager, Diamond Dispersions. “The Queen’s Award is an honor that is admired across the globe, not just in the UK – and it deeply matters to every one of us at Diamond Dispersions.”

“Over the last few years, our strategic planning has driven us to work more closely with print machine manufacturers (OEMS), enabling them to develop bespoke ink products,” shares Andrew Grantham, marketing manager, Diamond Dispersions. “The closer relationships we’ve built have been a key driver to our sales growth over the last three years.”

Diamond Dispersions has responded effectively to the rapidly growing digital print market by supporting customers as they seek to deliver customization, shorter print runs, just-in-time manufacturing and a desire for reduced stocks and wastage.

“We’ve also developed specific products for use in the pigmented digital textile printing market, which has huge potential for growth, “adds Grantham. “Pigment-based digital printing of cotton textiles, in particular, is much more environmentally friendly than dye-based printing as it requires less energy and water and eliminates waste-water effluent.”

“Ever since Diamond Dispersions was established in 2007, we have taken every opportunity to further improve and enhance our customer service,” concludes Grantham. “For example, to better serve customers locally and achieve the response times demanded by those customers, last year we made the decision to hold stock in several different countries including China, the US, India and Brazil.”

“The Queen’s Award is a great achievement and our whole team is justifiably very proud of the award,” shares Charles Nelson, general manager, Diamond Dispersions. “Lubrizol is planning further investments in the business to ensure we keep pace with growing demand.”

Diamond Dispersions will celebrate the award during a royal reception for Queen’s Awards’ winners in Summer 2019 and will host its own celebration in Sheffield in Autumn.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Looks to India for Expertise

(BRK.A), (BRK.B)

Lubrizol Advanced Materials India Pvt. Ltd. signed an agreement in February with The Institute of Chemical Technology (ICT) for the supply of technical services and new application development of Estane(R) thermoplastic polyurethane (TPU).

ICT is a leading chemical technology research university in Mumbai, India.

The agreement was signed by Ms. Ursula Thakkar, Managing Director, Lubrizol Advanced Materials, and Prof. G. D. Yadav, Vice Chancellor, ICT. The agreement sets the stage for a close collaboration that aims to develop new end-use applications in the Indian industrial sector. Speaking on this occasion, Ms. Ursula Thakkar, Managing Director South Asia said, “We are very pleased to partner with ICT as part of our strategy to provide innovative solutions for our customers in India”.

Dr. Jesus Santamaria, Regional business director for Engineered Polymers, EMEAI added: “India is one of the key regions that is contributing – and will contribute much more in the future – to our global business growth. We acknowledge the specificities of India as a market, different from other regions and, as such, deserving a differentiated support. Growing TPU applications in mobility, electronics and Industry 4.0 (digitalization and automation) are positioning India at the forefront of technology. This agreement is critical to this vision as it will complement our current global technical centers with a local support from one of the most globally recognized chemical technology institutions.”

Lubrizol Engineered Polymers has more than 60 years of experience and a worldwide network that includes formulation design, manufacturing, R&D and cutting-edge technologies.

Lubrizol Engineered Polymers offers one of the broadest portfolios of engineered polymers available today including resins that are bio-based, recyclable, light stable, flame retardant, adhesive, chemically resistant, optically clear and fast cycling. Our technology crosses many industries and applications, including surface protection, power and fluid systems, sports and recreation, wearable devices, electronics and automotive.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Plans Collaboration with CP Kelco

(BRK.A), (BRK.B)

The Lubrizol Corporation has formed an exclusive global collaboration with CP Kelco, servicing the personal and home care markets with PURLLON(TM) Cellulose Liquid and KELCO-VIS(TM) Diutan Gum products.

Based in Atlanta, Georgia, CP Kelco is a market leader offering innovative products and solutions using nature-based chemistry.

The new relationship combines Lubrizol’s formulation expertise with CP Kelco’s broad knowledge of more sustainable solutions. This allows our technical teams the ability to expand our formulation expertise, bringing innovative solutions with increased naturality without compromising performance.

With this collaboration, Lubrizol will exclusively service the personal and home care markets for CP Kelco’s innovative Fermentation Derived Cellulose & Diutan Gum technologies.

Vice president and general manager of Personal, Home and Health Care, Deb Langer states, “We are always looking for ways to expand our offerings to our partners and the team is excited to elevate our sustainable portfolio with CP Kelco® Fermentation Derived Cellulose and Diutan Gum products.”

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol Acquires Laboratoire Phenobio

(BRK.A), (BRK.B)

The Lubrizol Corporation has announced the acquisition of Laboratoire Phenobio, an innovative supplier of naturally-derived extracts and botanical active ingredients. Recognized across the world as a pioneer in botanical extracts and natural performance ingredients, this addition expands Lubrizol’s existing capabilities to provide clean natural ingredients across the cosmetic, nutraceutical and life sciences industries.

Located near the Bordeaux region in France, the company’s unique capabilities in subcritical water extraction (SWE) of botanical biomass, coupled with their energy-economic and eco-responsible technologies provide significant value to Lubrizol’s global sustainability efforts. This expertise includes a technology used to extract phytoactives from botanical raw materials and is also commonly known as pressurized low polarity water (PLPW). The technology involves extraction of a broad range of phytoactives that are not normally obtained with only water.

“Lubrizol continues to invest in innovative technologies to offer step change formulations for the personal care and life sciences markets” states Deb Langer, Lubrizol vice president and general manager of personal, home and healthcare. “With this acquisition, Lubrizol customers will have access to novel botanical extracts compliant with ECOCERT® and COSMOS standards that meet the naturality and sustainability expectations end users are requiring on a global basis. Additionally, our preferred partners will have access to final formulations using this exciting new technology.”

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.

Lubrizol LifeSciences Announces New Medical Device Applications Lab

(BRK.A), (BRK.B)

Berkshire Hathaway’s Lubrizol Corporation has announced that its LifeSciences business will feature a new medical device applications lab.

LifeSciences has invested significantly to expand its global development and manufacturing facilities, and the latest investment is a new state-of-the-art medical device applications lab in Brecksville, Ohio.

The lab features applications testing, small-scale compounding as well as injection molding for long-term implantables. The 1,800-square foot facility will also focus on accelerated R&D, from polymers to device scale up and testing in a short period of time.

“The new applications lab is another commitment to healthcare companies looking for a full-service development partner. We continue to invest in the right areas to provide valuable offerings where our customers are experiencing the most growth,” states Uwe Winzen, general manager, Lubrizol LifeSciences. “When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process.”

Offering more than 90 years of science and technology experience, Lubrizol is uniquely structured to partner with medical device manufacturers by providing proactive innovation, speed to market, and expertise for the most demanding projects. From materials to development and manufacturing, or anything in between – Lubrizol LifeSciences is equipped to support the needs of customers worldwide.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.